XOMA Corp
NASDAQ:XOMA
XOMA Corp
Cash
XOMA Corp
Cash Peer Comparison
Competitive Cash Analysis
Latest Figures & CAGR of Competitors
Company | Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
XOMA Corp
NASDAQ:XOMA
|
Cash
$136.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Cash
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is XOMA Corp's Cash?
Cash
136.2m
USD
Based on the financial report for Mar 31, 2024, XOMA Corp's Cash amounts to 136.2m USD.
What is XOMA Corp's Cash growth rate?
Cash CAGR 3Y
26%
Over the last year, the Cash growth was 208%. The average annual Cash growth rates for XOMA Corp have been 26% over the past three years .